Expression of the human germinal center–associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival

التفاصيل البيبلوغرافية
العنوان: Expression of the human germinal center–associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival
المؤلفون: Brad Pohlman, Izidore S. Lossos, Shuchun Zhao, Ronald Levy, Yasodha Natkunam, Patricia Aoun, Hina Naushad, Martin Bast, Eric D. Hsi, Paul Elson
المصدر: Blood. 109:298-305
بيانات النشر: American Society of Hematology, 2006.
سنة النشر: 2006
مصطلحات موضوعية: Male, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Kaplan-Meier Estimate, Biochemistry, Cohort Studies, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, RNA, Neoplasm, Neprilysin, Aged, 80 and over, B-Lymphocytes, Univariate analysis, Tissue microarray, Microfilament Proteins, Age Factors, Intracellular Signaling Peptides and Proteins, Hematology, Middle Aged, BCL6, Combined Modality Therapy, Hodgkin Disease, Neoplasm Proteins, DNA-Binding Proteins, Gene Expression Regulation, Neoplastic, Interferon Regulatory Factors, Proto-Oncogene Proteins c-bcl-6, RNA, Viral, Female, Adult, Risk, Immunology, Biology, Disease-Free Survival, Statistics, Nonparametric, Biomarkers, Tumor, medicine, Humans, RNA, Messenger, Epstein–Barr virus infection, Aged, Proportional Hazards Models, Neoplasia, Interleukins, Germinal center, Cell Biology, Germinal Center, medicine.disease, Lymphoma, Repressor Proteins, Cancer research, Positive Regulatory Domain I-Binding Factor 1, Transcription Factors, IRF4
الوصف: The human germinal-center–associated lymphoma (HGAL) gene and its cognate protein are expressed in a germinal center (GC)–specific manner. Its expression in classic Hodgkin lymphoma (cHL) prompted us to address whether HGAL expression could distinguish biologically distinct subgroups of cHL. Tissue microarrays from 145 patients treated with curative intent showed HGAL staining in 75% and was closely correlated with MUM1/IRF4 (92%) expression. BCL6 (26%), CD10 (0%), BCL2 (31%), Blimp1 (0.02%), and Epstein-Barr virus (EBV) (20%) showed no specific correlation; neither did phospho-STAT6, a key mediator of IL-4 and IL-13 signaling that induces HGAL and is implicated in cHL pathogenesis. In our study cohort, the 5-year overall survival (OS) correlated with young age (less than 45 years, P < .001), low stage (stage I and II, P = .04), and low International Prognostic Score (P = .002). In univariate analysis, HGAL expression was associated with improved OS (P = .01) and failure-free survival (FFS) (P = .05) but was not independent of other factors in multivariate analysis of OS or FFS. The expression of the GC-specific marker HGAL in a subset of cHL suggests that these cHLs retain characteristics of GC-derived lymphomas. The association with improved OS in univariate but not multivariate analysis suggests that HGAL expression is related to known clinical parameters of improved survival.
تدمد: 1528-0020
0006-4971
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07020f45de264e6a3fa48c74fb56b39Test
https://doi.org/10.1182/blood-2006-04-014977Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....a07020f45de264e6a3fa48c74fb56b39
قاعدة البيانات: OpenAIRE